Viking Therapeutics Oral Antiobesity Agent Returns Positive Results in Small Study.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article
Works matching DE "VIKING Therapeutics Inc."
Results: 2
1
2
Viking Therapeutics Dual GIP/GLP-1 Mimetic Drives Weight Loss of Up to 14.7% in Phase 2 Findings.
- Published in:
- Patient Care (Online), 2024, p. 1
- By:
- Publication type:
- Article